Vicore Pharma AB Statistics

NASDAQ: VCREHealth CareBiotechnology: Pharmaceutical PreparationsUSD

8.48-0.18 (-2.08%)

Market open · Delayed 15 min · as of Oct 8, 11:35 AM ET

Vicore Pharma AB by the numbers

Vicore Pharma AB has a market capitalization of $238.8 million based on 28.16M shares outstanding. With trailing EPS of $-2.04, Vicore Pharma AB is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 23.2% below its 50-day average and 25.8% below its 200-day average.

Average daily trading volume is 16.24K shares, or about $137,690 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

VCRE valuation vs. peer median

VCRE compared with the median of 8 peer companies
Metric	VCRE	Peer median	Difference
Market cap	$238.83M	$240.45M	-1%
Avg. volume	16.24K	449.64K	-96%

Peer median across 8 companies: LFCR, UPB, VOGX, AMRN, ZNTL, IMRX, ACIU, AKBA.

Valuation

Market cap: $238.83M
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-2.04
Shares outstanding: 28.16M

Price and trading

Previous close: 8.66
Open: 8.78
Day range: 8.47 – 8.79
52-week range: 7.88 – 17.80
50-day moving average: 11.04
200-day moving average: 11.43
Beta: —
Volume: 13.69K
Average volume: 16.24K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: —

Additional statistics

Market Cap: 238.83M
Eps: -2.04
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 17.80
Week52 Low: 7.88
Avg Volume: 16,237.00
Shares Outstanding: 28.16M
Ma50: 11.04
Ma200: 11.43
Pct From52w High: -52.36%
Pct From52w Low: 7.61%